Nvidia’s Blackwell, Quantum-AI Drive 72% FY2027 Growth and $265 Target
Nvidia’s Blackwell architecture and quantum-AI models underpin a projected 72% revenue gain in FY2027, supporting a $265 price target with 32% upside. AI expansion into drug discovery and narrowing market-cap gap to under $200 billion reinforce Nvidia’s leadership and prompt analyst buy over Intel sell.
1. Next-Gen AI Architectures
Nvidia unveiled its Blackwell GPU architecture and new quantum-AI models, delivering up to twice the performance per watt and enabling advanced deep learning and simulation workloads.
2. Financial Projections and Price Target
Management forecasts FY2027 revenue growth of roughly 72%, compressing forward P/E to ~24x and P/S to ~13x, while a $265 price target implies 32% upside for shareholders.
3. AI-Driven Drug Discovery
The company’s GPUs are powering AI-based drug discovery efforts, accelerating molecular simulations and candidate screening for pharmaceutical partners and opening a new market beyond traditional chip sales.
4. Competitive Position and Market-Cap Gap
Nvidia’s market-cap deficit versus Alphabet shrank to below $200 billion, strengthening its position as the world’s second-largest public company, and analysts recommend buying Nvidia while advising a sell on Intel.